Home/Filings/4/0001179110-21-000338
4//SEC Filing

Kirby John J. 4

Accession 0001179110-21-000338

CIK 0000861838other

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 5:04 PM ET

Size

5.3 KB

Accession

0001179110-21-000338

Insider Transaction Report

Form 4
Period: 2021-01-05
Kirby John J.
V.P. of Finance, PFO & PAO
Transactions
  • Sale

    Common Stock

    2021-01-05$3.90/sh862$3,36235,575 total
Footnotes (2)
  • [F1]Represents the number of shares of Issuer common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 2,563 Restricted Stock Units ("RSUs") on January 3, 2021. This sale is mandated by the Issuer's election under its 2013 Stock Incentive Plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
  • [F2]Of the reported securities beneficially owned, 25,125 shares are represented by unvested RSUs.

Issuer

IDERA PHARMACEUTICALS, INC.

CIK 0000861838

Entity typeother

Related Parties

1
  • filerCIK 0001556327

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 5:04 PM ET
Size
5.3 KB